Outcomes of permanent pacemakers and implantable cardioverter-defibrillators in an adult congenital heart disease population

Background: Brady- and tachyarrhythmias commonly complicate adult congenital heart disease (ACHD). Permanent pacemakers (PPMs) or implantable cardioverter–defibrillators (ICDs) are often utilised to prevent morbidity or mortality related to arrhythmia, but can also be associated with significant mor...

Full description

Bibliographic Details
Published in:	International Journal of Cardiology Congenital Heart Disease
Main Authors:	Jason Chami, Benjamin M. Moore, Calum Nicholson, Rachael Cordina, David Baker, David S. Celermajer
Format:	Article
Language:	English
Published:	Elsevier 2024-03-01
Subjects:	Adult congenital heart disease Arrhythmia Implantable devices Pacemakers Implantable cardioverter-defibrillators
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666668523000526

Similar Items

Short-term Venous Patency after Implantation of Permanent Pacemakers or Implantable Cardioverter Defibrillators
by: Takeshi Nakae, MD, et al.
Published: (2010-01-01)

Managing cross talk between a subcutaneous implantable cardioverter-defibrillator and a dual-chamber unipolar pacemaker system
by: Konstantinos Kossidas, MD, FHRS, et al.
Published: (2017-12-01)

Lead Extractions are not Necessarily Required in the Treatment of Cases with Local Complications Unproven Resional/systemic Infection at the Pacemaker/ implantable Cardioverter Defibrillator (ICD) Site
by: Ryoji Kishi, MD, et al.
Published: (2005-01-01)

Relation of Supraventricular Arrhythmias Detected by Implantable Cardioverter Defibrillator and Air Pollutants
by: Javad Shahabi, et al.
Published: (2024-08-01)

The effect of air pollution on ventricular arrhythmias in patients with implantable cardioverter defibrillator
by: Javad Shahabi, et al.
Published: (2023-01-01)

Epicardial cardioverter defibrillator implantation due to post-fontan ventricular tachycardia
by: Nikolaos A Papakonstantinou, et al.
Published: (2020-01-01)

Stepwise cardiac rehabilitation adjustment after exercise-induced implantable cardioverter defibrillator shock: a case report
by: Hidetoshi Yanagi, et al.
Published: (2025-04-01)

Prophylactic implantation of cardioverter‐defibrillator in patients with advanced light‐chain amyloidosis—A pilot study
by: Hui‐Qiang Wei, et al.
Published: (2025-04-01)

Subcutaneous defibrillator use with unipolar pacemakers: Cautiously possible
by: Matanyahu Rubinstein, et al.
Published: (2023-07-01)

Incidence, Predictors, and Outcomes of Implantable Cardioverter‐Defibrillator Discharge Among People Living With HIV
by: Raza M. Alvi, et al.
Published: (2018-09-01)

Current status of wearable cardioverter‐defibrillator use in Japan
by: Reina Tonegawa‐Kuji, et al.
Published: (2024-08-01)

The association between statin dosage and malignant ventricular arrhythmias in patients with primary prevention implantable cardioverter-defibrillators for ischemic cardiomyopathy
by: Özge Çakmak Karaaslan, et al.
Published: (2023-01-01)

Intermuscular pocket for subcutaneous implantable cardioverter defibrillator: Single-center experience
by: Paola Ferrari, MD, et al.
Published: (2016-06-01)

Feasibility of adenosine stress cardiovascular magnetic resonance perfusion imaging in patients with MR-conditional transvenous permanent pacemakers and defibrillators
by: Anna Giulia Pavon, et al.
Published: (2022-01-01)

Outcomes during and after the use of the wearable cardioverter-defibrillator in a tertiary-care and a regional hospital in Switzerland
by: Boldizsar Kovacs, et al.
Published: (2019-11-01)

Mycobacterium fortuitum causing infection of a biventricular pacemaker/implantable cardioverter defibrillator
by: Yuhning L Hu, et al.
Published: (2012-01-01)

Implantable cardioverter-defibrillator programming after first occurrence of ventricular tachycardia in the Multicenter Automatic Defibrillator Implantation Trial–Reduce Inappropriate Therapy (MADIT-RIT)Key Findings
by: Mehmet K. Aktas, MD, MBA, FHRS, et al.
Published: (2020-06-01)

Implantation of Implantable Cardioverter Defibrillators in Kazakhstan
by: Temirkhan Begisbayev, et al.
Published: (2022-05-01)

Subcutaneous Implantable Cardioverter-defibrillator in Preventing Ventricular Arrhythmia and Sudden Cardiac Death – A Single-center Experience
by: Amarapalli Jayachandra, et al.
Published: (2024-08-01)

Psychological Problems of Patients with Implantable Cardioverter Defibrillators in Baghdad City.
by: Bayda'a A. Kareem
Published: (2014-04-01)

An unusual cause of implantable cardioverter defibrillator malfunction: Twiddler syndrome
by: Ufuk Eryılmaz, et al.
Published: (2013-10-01)

Implantable Cardioverter Defibrillator Tachycardia Therapies: Past, Present and Future Directions
by: Andrew M. Leong, et al.
Published: (2024-03-01)

Upper extremity deep venous thrombosis and stenosis after implantation of pacemakers and defibrillators; A prospective study
by: Safi Morteza, et al.
Published: (2017-09-01)

Underrepresentation of women in implantable cardioverter defibrillator trials
by: Janet K. Han, et al.
Published: (2022-02-01)

Prognostic comparison between implantable cardioverter‐defibrillator and amiodarone in cancer patients
by: Hirota Kida, et al.
Published: (2025-06-01)

“Real-world” analysis of battery longevity of implantable cardioverter-defibrillators: an in-depth analysis of a prospective defibrillator database
by: Diogo de Almeida Fernandes, et al.
Published: (2023-12-01)

Cardiac implantable electronic devices in Bulgaria: results from the electronic registry BG-Pace for 2022
by: V. Traykov, et al.
Published: (2023-12-01)

Patient characteristics and in‐hospital complications of subcutaneous implantable cardioverter‐defibrillator for Brugada syndrome in Japan
by: Iwanari Kawamura, et al.
Published: (2019-12-01)

Subcutaneous cardioverter-defibrillator implantation in an adult with congenital heart disease and left infra-mammary pacemaker
by: Soham Dasgupta, et al.
Published: (2024-03-01)

Use of the wearable cardioverter-defibrillator – the Swiss experience
by: Boldizsar Kovacs, et al.
Published: (2020-09-01)

Multiple Implantable Cardioverter-Defibrillator Shocks in Ischemic Cardiomyopathy Compels Coronary Vascularization Reassessment
by: Guşetu Gabriel, et al.
Published: (2023-12-01)

Arrhythmia Risk During the 2016 US Presidential Election: The Cost of Stressful Politics
by: Lindsey Rosman, et al.
Published: (2021-06-01)

Implantable cardioverter defibrillators for primary prevention in cardiomyopathies
by: Vineetha Kanneganti, et al.
Published: (2024-03-01)

Dosimetric feasibility of stereotactic arrhythmia radioablation for ventricular tachycardia in patients with a subcutaneous implantable cardioverter defibrillator
by: Lena Kaestner, et al.
Published: (2025-07-01)

Eligibility for subcutaneous implantable cardioverter‐defibrillator in adults with congenital heart disease
by: Christos Zormpas, et al.
Published: (2021-04-01)

Patients’ Knowledge about Safe Measures Post Implantable Cardioverter Defibrillator
by: Mohammed Kadhum Sadaq, et al.
Published: (2025-09-01)

Sudden Death Due to Thrombosis Associated with Implantable Cardioverter-Defibrillator Electrodes
by: Jose Maria Frutos Perez, et al.
Published: (2021-03-01)

Adaptation status and related factors in patients living with implantable cardioverter defibrillators
by: Mohammadreza Razavi, et al.
Published: (2022-01-01)

Long‐term safety and efficacy of subcutaneous implantable cardioverter‐defibrillator compared with transvenous implantable cardioverter‐defibrillator in propensity score‐matched patients from Japan
by: Yuki Konno, et al.
Published: (2025-04-01)

Ventricular arrhythmia burden in patients with implantable cardioverter defibrillator and remote patient monitoring during different time intervals of the COVID-19 pandemic
by: Christian Hauck, et al.
Published: (2022-11-01)